Also Known as “The Body’s Own Cannabinoid System"
Endocannabinoids in the body are degraded by fatty acid amide hydrolase (FAAH). Cannabidiol (CBD), another component of medical marijuana, inhibits FAAH, allowing more naturally-occurring endocannabinoids to remain active in the body.
Imbalances of the endocannabinoid system are associated with many diseases, explaining why medical marijuana has a beneficial effect on a variety of medical conditions.
Current research on the endocannabinoid system is seeking new treatments for autoimmune, inflammatory, and neurodegenerative diseases, as well as non-addictive ways to relieve pain.
The delta9-Tetrahydrocannabinol (THC) in marijuana resembles the endocannabinoid molecules, anandamide and 2-Ag, manufactured by the human body. THC binds with CB1 and CB2 receptors to replace or augment naturally-occurring endocannabinoid.